AB-Biotics has announced, as a relevant fact, that the offer to acquire shares of Kaneka, in the context of the delisting of the Spanish company, has been accepted by 2,292. 426 shares, an amount that represents 57.62% of the shares to the offerees and 18.21% of the company's share capital. In addition, through the aforementioned offer and different purchases made, Kaneka has acquired 259,762 shares in...